title: Conjugate of bovine hemoglobin and human serum albumin as a candidate for blood substitute: characteristics and effects on rats.
abstract: Conjugate of bovine hemoglobin (bHb) and human serum albumin (HSA) was prepared. The product was simply composed of 89.7% one-to-one Hb-HSA conjugate, 6.0% oligomer of Hb and HSA, 3.5% unconjugated HSA and 0.8% unconjugated Hb, with an average molecular weight of 157 kD. The physicochemical characteristics were determined. Effects of single replacement on blood pressure and long-term survival of rats with 30% and 60% acute blood loss were studied, in comparison with Ringer-lactate solution, stroma-free hemoglobin (SFHb), 5% HSA in Ringer-lactate, whole blood and no resuscitation fluid. Results showed that Hb-HSA conjugate maintained the mean arterial pressure of rats to initial level with no pressor effect. Long-term effects of the replacement fluids on 30% bleeding rats showed that, for the group infused with Hb-HSA conjugate, histology of five major organs, heart, kidney, liver, spleen and lung, were essentially normal, similar to that of whole blood, while obviously renal side-effects appeared in other groups. The efficacy of the conjugate was further demonstrated by the resuscitation of lethal hemorrhagic shock rats (60% acute blood loss) with 100% survival rate (followed for 14 days), the same result as whole blood. The Hb-HSA conjugate can thus be another candidate for blood substitute in emergency.
authors.affiliation: National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
authors.forename: Xiu-Ling
authors.initials: XL
authors.lastname: Lu
authors.forename: Chun-Yang
authors.initials: CY
authors.lastname: Zheng
authors.lastname: Xiao-DongShi
authors.forename: Yong-Quan
authors.initials: YQ
authors.lastname: Wang
authors.forename: Xiao-Yan
authors.initials: XY
authors.lastname: Suo
authors.forename: Peng-Zhan
authors.initials: PZ
authors.lastname: Yu
authors.forename: Yu-Hong
authors.initials: YH
authors.lastname: Xu
authors.forename: Tie-Min
authors.initials: TM
authors.lastname: Ma
authors.forename: Zhi-Guo
authors.initials: ZG
authors.lastname: Su
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001802:Blood Substitutes / Q000138:chemical synthesis* / Q000627:therapeutic use; D002417:Cattle; D019281:Dimerization; D006454:Hemoglobins / Q000737:chemistry / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D011108:Polymers / Q000138:chemical synthesis / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012709:Serum Albumin / Q000737:chemistry / Q000627:therapeutic use*; D012771:Shock, Hemorrhagic / Q000188:drug therapy; D015996:Survival Rate
chemical_list: D001802:Blood Substitutes; D006454:Hemoglobins; D011108:Polymers; D012709:Serum Albumin